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Regions of the Torpedo marmorata cetylcholine r ceptor (AChR) c~-subunit involved in the binding of ace- 
tylcholine were probed with two different covalent ligands. The sulfhydryl-directed affinity reagent 4-(N- 
maleimido)phenyltrimethylammonium i d de labeled a single ~-subunit cyanogen bromide fragment on the 
reduced AChR which was identified as ~ 17%207. The novel photoaffinity ligand p-(N,N-dimethylamino)- 
benzenediazonium fluoroborate, on the other hand, labeled three distinct a-chain cyanogen bromide frag- 
ments on the unmodified AChR in a carbamylcholine-protectable manner. The major radiolabeled species 
was purified and identified by sequence analysis as ~ 179-207. The acetylcholine-binding site on the native 
AChR may thus involve several distinct portions of the c~-chain, with the region :~ 179-207 making a major 
contribution to the site. 
Acetyh'holine r ceptor Photoaffinity labeling Protein structure 
Aryldiazonium salt 
A cetyh'holine-binding site 
I. INTRODUCTION 
The nicotinic acetylcholine receptor (AChR) 
mediates the permeability response to acetylcho- 
line (ACh) at the vertebrate neuromuscular junc- 
tion and the electromotor synapse of Torpedo fish. 
The minimal functional unit is a heterologous pen- 
tamer of four different polypeptide chains (o~z6'76) 
which carries two binding sites for ACh located, at 
Abbreviations: HPLC, high-performance liquid 
chromatography; TFA, trifluoroacetic acid; HFBA, 
heptafluorobutyric acid 
least in part, on the two c~-chains, and contains the 
agonist-gated ion channel (review [11). 
The complete primary structures of the four 
AChR polypeptides in Torpedo californica [2,3], 
of the ,z-chain in T. marmorata [3,] and of various 
chains in several other species (review [5]) have 
been elucidated by DNA cloning and sequencing. 
A major goal of current research on the AChR is 
to localize functional domains within the known 
amino acid sequence of the constituent polypeptide 
chains. One approach consists in the labeling of 
pharmacological sites using appropriate covalent 
ligands and the identification of the modified 
amino acids by protein chemical techniques (e.g. 
[6,7]). 
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In the case of the ACh-binding sites, the reduc- 
tion of a disulfide bond in the vicinity of the 
tetraalkylammonium-binding s te permits labeling 
of the ~-subunit by cholinergic affinity ligands 
specific for sulfhydryl groups [8]. Employing one 
such ligand, 4-(N-maleimido)benzyltrimethylam- 
monium iodide (MBTA), Kao et al. [6] were able 
to demonstrate that the residues Cys 192, and 
possibly Cys 193, represent the sites of incorpora- 
tion of this class of affinity ligands on the reduced 
AChR. Owing to the limited reactivity of such 
reagents, however, it is unclear to what extent he 
region surrounding Cys 192 and 193 participates in
the binding of ACh in the native AChR. Further- 
more, reduction of the disulfide bond which links 
these consecutive Cys residues [9] produces 
marked alterations in the affinity and selectivity of 
the AChR for cholinergic ligands [8,10]. 
In order to probe in greater detail the structure 
of the ACh-binding site on the native AChR, we 
employed a recently developed photoaffinity 
ligand p-(N,N-dimethylamino)benzenediazonium 
fluoroborate (DDF) [11], a stable derivative of a 
previously described cholinergic affinity reagent 
[12,13]. Photolabeling experiments using [3H]DDF 
recently permitted the identification of a peptide 
fragment localized in the tetraalkylammonium- 
binding site on Electrophorus electricus 
acetylcholinesterase [14]. As described in a 
separate report (submitted), DDF can also be used 
to label the ACh-binding sites on the AChR. In the 
dark, DDF behaves as a reversible competitive an- 
tagonist of the AChR but irreversibly blocks the 
binding of cholinergic ligands following irradia- 
tion at 295 nm. Under appropriate conditions, 
labeling of the native AChR by [3H]DDF is 
associated predominantly with the o~-subunit and is 
protected by cholinergic agonists and antagonists. 
Here, we have analyzed the regions of the o~- 
subunit labeled by [3H]DDF via the ACh-binding 
sites on native AChR. The resulting pattern of 
labeling was compared with that obtained for the 
sulfhydryl-specific affinity reagent 4-(N-malei- 
mido)phenyltrimethylammonium iodide ([3H]- 
MPTA) on reduced AChR. Our findings indicate 
that [3H]DDF is incorporated at multiple sites on 
the c~-subunit, but that the majority of the photo- 
labeling is associated with a fragment con- 
taining the residues Cys 192 and 193 labeled by 
[3H]MPTA. 
2. EXPERIMENTAL 
Methyl[3H]DDF (1 Ci/mmol) was synthesized 
and purified as in [15]. MethyI[3H]MPTA 
(10Ci/mmol) was obtained from the Com- 
missariat/a l'Energie Atomique (Saclay) and phen- 
cyclidine was generously provided by A. 
Jaganathen (Universit6 Louis Pasteur, Stras- 
bourg). Native and lZSI-labeled o~-bungarotoxin 
were from Boehringer/Mannheim and Amersham, 
respectively, carbamylcholine from Sigma and 
CNBr from Kodak. Live T. marmorata were pro- 
vided by the Biological Station of Arcachon 
(France). 
AChR-rich membrane fragments were purified 
and alkali-treated as described [16,17]. For affinity 
alkylation with [3H]MPTA, the membranes (1#M 
o~-toxin sites) were preincubated for 45 min under 
nitrogen at 22°C with 0.3 mM dithiothreitol in 
15 mM Tris-HC1, 150 mM NaC1, 1.5 mM EDTA, 
pH 8.0. After reduction, the pH was adjusted to 7 
by addition of 0.5 M sodium phosphate buffer, 
pH 6.7, and isotopically diluted [3H]MPTA 
(0.5 Ci/mmol) added to a final concentration of 
5 #M; a control aliquot of this mixture had been 
preincubated with 7/~M o~-bungarotoxin. Follow- 
ing 10 min at room temperature, the reaction was 
quenched with/Y-mercaptoethanol and the mem- 
branes washed by centrifugation. 
Photolabeling of AChR-rich membranes with 
[3H]DDF was performed as described in [15] with 
the following modifications. Membranes (1/~M o~- 
toxin sites in 10 mM sodium phosphate buffer, pH 
7.0) were preincubated for 30 min at 10°C with 
100/~M phencyclidine to block the high-affinity 
binding site for noncompetitive blockers [15]. 
[3H]DDF was then added to a final concentration 
of 0.2 mM; control incubations involved a 30 rain 
preincubation with 100/~M carbamylcholine. The 
suspensions (0.5 ml) were irradiated with 
monochromatic light (295 nm) for 30 min at 10°C 
with mixing and then the membranes washed by 
centrifugation. Based on the number of toxin- 
binding sites measured [18] before and after label- 
ing, [3H]MPTA ad [3H]DDF were incorporated in- 
to approx. 60 and 50°70, respectively, of the 
available ACh-binding sites. 
The labeled membranes were solubilized in SDS 
sample buffer [19], aliquots were run on analytical 
slab gels (10% polyacrylamide/0.13% bisacryl- 
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amide) and the incorporation of radioactivity into 
the AChR subunits quantified as in [20]. The re- 
mainder was subjected to preparative SDS-poly- 
acrylamide gel electrophoresis [211 and the 
a-subunit cut out and eluted from the gels [7]. 
Following dialysis, lyophilization, carboxymethy- 
lation and acetone precipitation [7], the purified o~- 
chain was dissolved in 70o70 formic acid and 
cleaved with CNBr [22]. 
The HPLC system used for peptide fractiona- 
tions was from Waters and was equipped with an 
Anacomp controller/data module (Kontron) and a 
Valco injector. Gel-permeation HPLC was per- 
formed on two TSK 125 columns (Bio-Rad) con- 
nected in series and run with 8 M urea/10% acetic 
acid. Reversed-phase HPLC was done on a Waters 
#bondapak C18 column (3.9 x 300 mm) eluted with 
gradients of 90°70 1-propanol in either 0.1070 TFA 
or 0.13% HFBA. 
Purified CNBr fragments were subjected to 
automated Edman degradation on a gas-phase se- 
quenator (Applied Biosystems) [231. Aliquots of 
each cycle were used for PTH-amino acid iden- 
tification by HPLC [24] or for radioactivity 
measurement. 
3. RESULTS 
Batches of AChR-rich membrane fragments (ap- 
prox. 100-200 nmol a-toxin-binding sites) were 
either photolabeled with [3H]DDF, or labeled with 
[3H]MPTA after dithiothreitol treatment. The 
AChR a-chain, which in both cases incorporated 
the radioactivity predominantly, was then purified 
by preparative polyacrylamide gel electrophoresis. 
Addition of specific ligands for the ACh-binding 
site markedly reduced the labeling of this par- 
ticular chain; the incorporation of [3H]DDF was 
inhibited by 7507o in the presence of  100#M car- 
bamylcholine, while that of [3H]MPTA was 
decreased 90°70 by 7/zM a-bungarotoxin. 
The distribution of these two compounds within 
the ce-chain was compared on radioactive peptide 
maps. Analysis of small aliquots of the total CNBr 
digests of purified labeled a-chains by reversed- 
phase HPLC yielded the radioactivity profiles 
shown in fig.l. A major radioactive peak eluting 
between 35 and 39 min represented 54°70 of the 
eluted [3H]DDF-labeled material (II in fig. IA), the 
remainder being distributed mainly in two peaks 
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Fig.1. Analytical peptide maps of [3H]MPTA- and 
[3H]DDF-labeled o~-chain CNBr digests. Aliquots of the 
total CNBr digests of labeled o~-chain 70070 formic acid 
were diluted with 0.1°70 TFA/10070 l-propanol and 
subjected to reversed-phase HPLC using the gradient of 
solvent B (90°7o 1-propanol/0.1 °7oTFA) shown in A at a 
flow rate of 0.7 ml/min. Radioactivity in 0.Tml 
fractions was measured by liquid scintillation counting, 
The formulae of the covalent ligands employed are 
shown as insets. (A) Radioactivity profiles observed with 
CNBr digests of equivalent amounts of o:-chain labeled 
by [~H]DDF in the absence (.) and presence (o) of 
100 #M carbamylcholine. I-II1 denote peaks of specific 
labeling by [3H]DDF. In both cases, the recovery of 
injected radioactivity was 66%. (B) Radioactivity profile 
observed with CNBr digest of [3H]MPTA-labeled o~- 
chain. The recovery of injected radioactivity was 75070. 
eluting between 29 and 32 min (I) and 41-45 min 
(III). The incorporation of [3H]DDF into peaks 
I - I I I  was markedly reduced (by 65-80°70) when 
photolabeling was performed in the presence of 
carbamylcholine (open circles in fig. 1A); [3H]DDF 
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Fig.2. Preparative gel permeation HPLC of the CNBr 
digest of [3H]DDF-labeled G-chain. (A) The dried CNBr 
digest was solubilized in 8 M urea/10% acetic acid 
(approx. 1 mg protein/ml) and 200 #1 aliquots ubjected 
to gel permeation HPLC at a flow rate of 0.5 ml/min as 
described in section 2. The absorbance of column eluates 
was monitored on line at 240 nm (solid line). 
Radioactivity in the fractions (0.5 ml) was measured in
aliquots (2/A) by liquid scintillation counting (o). 
Radioactivity in eluate fractions for the carbamylcho- 
line-protected batch analyzed in parallel (O) have been 
normalized to equivalent amounts of protein. The bar 
denotes fractions pooled for further purification. (B) 
Calibration curve for the gel permeation HPLC system. 
The Kay was calculated as (Vt - V~) / (Vt  - Vo), where Vt, 
V0 and Ve represent elution times for the total volume 
(dinitrophenyllysine), void volume (bovine serum 
albumin) and sample, respectively. Kay is plotted vs Iog~o 
Mr for the standard proteins: (1) chymotrypsinogen A 
(Mr 25000); (2) ribonuclease A (M, 14000); (3) insulin 
(Mr 5700); and (4) gramicidin S (M, 1100). The arrow 
denotes the K,v observed for the major [3H]DDF-labeled 
peak. 
thus appeared to label specifically various o~-chain 
CNBr fragments. With [3H]MPTA-labeled 
material, on the other hand, a single peak o f  
radioactivity was observed (fig. 1B) which eluted in 
the same region of the chromatogram as the  
predominant [3H]DDF-labeled component (II in  
fig.lA). To establish whether these radioactive 
species corresponded to the same peptide, they 
were purified to homogeneity and sequenced. 
Preparative purification of the major [3H]DDF- 
labeled species (If in fig.lA) was achieved by a 
combination of gel permeation and reversed-phase 
HPLC. Size fractionation of the a-chain CNBr  
digest solubilized in urea/acetic acid resolved 
numerous UV-absorbing species (fig.2A). The ma-  
jority of the [3H]DDF-labeled material eluted with 
an apparent molecular mass of 4 kDa (fig.2B). The  
carbamylcholine-protected sample showed a 
75-80% reduction in the extent of [3H]DDF label- 
ing of this peak. The corresponding fractions were 
pooled and subjected to reversed-phase HPLC in  
0.1% TFA (fig.3A). Two [3H]DDF-labeled com-  
ponents, corresponding to peaks I and II in the  
analytical peptide maps (cf. fig.l), were resolved; 
labeling of both was reduced by carbamylcholine. 
The fractions containing the principal radioactive 
peak (II) were pooled and rechromatographed on  
the same column using 0.13% HFBA as  
counterion. In this last system, a symmetrical peak 
of carbamylcholine-protectable radioactivity cor-  
responding to a well resolved peak in the absor- 
bance profile was observed (fig.3B). The  
radioactivity associated with this purif ied 
[3H]DDF-labeled species represented approx. 5°7o 
of that present in the uncut cx-chain used. This  
value reflects the recoveries of radioactivity for the 
purification procedures (approx. 75% for each 
HPLC system) as well as the proportion of the ,a-- 
chain labeling associated with this major radioac- 
tive component (approx. 50%). 
Preparative purification of the [3H]MPTA- 
labeled peptide was performed in parallel follow- 
ing exactly the same procedure. In all three HPLC 
steps, the [3H]MPTA-labeled material yielded ab- 
sorbance profiles identical with those in figs 2 and 
3, but a single radioactive component whicl7 
coeluted with the major [3H]DDF-labeled specie~ 
(not shown). The purified fragment contained ap.  
prox. 10°70 of the initial [3H]MPTA radioactivit5 
present in the o~-chain. 
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Fig.3. Purification of the major [3H]DDF-labeled CNBr 
fragment by reversed-phase HPLC. (A) Fractions 
containing the major [3H]DDF-labeled peak in fig.2 
were subjected irectly to reversed-phase HPLC in 0.107o 
TFA and eluted with the indicated gradient of solvent B 
(90°70 1-propanol/0.1% TFA) at a flow rate of 
0.7 ml/min. Absorbance of column eluates was 
monitored on line at 210 nm (solid line) and 
radioactivity measured in 2,ul aliquots of I min 
fractions (e). Radioactivity in eluate fractions for the 
carbamylcholine-protected batch (o) has been 
normalized to equivalent amounts of protein. The bar 
indicates fractions pooled for repurification. (B) Peak 
fractions from A were pooled, diluted with an equal 
volume of 0.13070 HFBA and subjected to reversed- 
phase HPLC using 9007o 1-propanol/0.13070 HFBA as 
solvent B and the gradient indicated in the upper panel. 
Details are as described in A. 
Following a final HPLC run in the 0.1% TFA 
HPLC system, the purified [3H]MPTA- and 
[3H]DDF-labeled components were subjected 
separately to sequence analysis (fig.4). In the case 
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Fig.4. Sequence analysis of [3H]MPTA- and [~H]DDF- 
labeled CNBr fragments. The major [~H]DDF- and 
[3H]MPTA-labeled CNBr fragments purified by HPLC 
were dissolved in 50°70 formic acid and then loaded onto 
glass-fiber filters which had been pretreated with 
polybrene and precycled 5 times before sequencing on 
the gas-phase sequenator. Yields of PTH-amino acids 
observed upon sequence analysis of the [3H]MPTA- (O) 
or of the [3H]DDF- (e) labeled fragments are plotted 
against cycle number. Repetitive yields of approx. 80070 
were calculated by linear regression analyses of the data 
(solid lines). 
of the [3H]MPTA-labeled fragment, PTH-amino 
acids could be identified up to cycle 12. A unique 
amino-terminal sequence was observed which, by 
comparison with the known sequence of the a,- 
subunit from T. marmorata [4], corresponded 
unambiguously to a CNBr fragment extending 
from Lys 179 (cleavage after Met 178). Measure- 
ment of the radioactivity released on each cycle up 
to residue 19 revealed a clear release of tritium at 
cycles 14 and 15 (not shown), corresponding to Cys 
192 and Cys 193 of the oe-subunit; these residues 
are thus labeled by [3H]MPTA. This result con- 
firms the original observation of Kao et al. [6] 
which demonstrated that o~ Cys 192, and possibly 
Cys 193, of T. californica were labeled by the 
closely related [3H]MBTA. 
The purified [3H]DDF-labeled fragment ex- 
hibited the same unique amino-terminal sequence 
beginning at Lys 179 (rigA); no release of radioac- 
tivity was observed for the five sequence cycles 
yielding identifiable PTH-amino acids. Based on 
its apparent molecular mass of 4 kDa (fig.2) this 
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radioactive peptide most probably extends to the 
next possible CNBr cleavage site at Met 207 
(calculated molecular mass = 3687 Da). 
Photolabeling by [3H]DDF of the ACh-binding 
site on the native receptor thus occurs 
predominantly in the region cr 179-207, which 
contains the residues Cys 192-Cys 193 labeled by 
[3H]MBTA and [3H]MPTA on the reduced 
receptor. 
4. DISCUSSION 
The regions of the AChR cr-subunit involved in 
the binding of cholinergic ligands were probed in 
the present study using the novel photoaffinity 
ligand [3H]DDF. This reagent offers significant 
advantages over the sulfhydryl-directed affinity 
markers in that: (i) it covalently labels the ACh- 
binding site in the native AChR without prior 
reduction, a modification known to produce 
marked changes in the conformation of this site 
[8,10]; (ii) the photogenerated aryl cation can react 
with any functional groups located in the im- 
mediate vicinity [14]; and (iii) the photolabile 
diazonium moiety may interact directly with the 
residue(s) forming the tetraalkylammonium- 
binding site [25]. 
Comparative peptide mapping of the 
[3H]MPTA- and [3H]DDF-labeled ot-subunit in- 
dicated differences in the distribution of the two 
markers within this chain. Whereas the incor- 
porated [3H]MPTA was associated with a single a- 
chain CNBr fragment, [3H]DDF appeared to label 
three distinct fragments in a carbamylcholine- 
sensitive manner. 
Purification and amino-terminal sequence 
analysis of the predominant [3H]DDF-labeled 
fragment permitted its identification as the seg- 
ment oz 179-207. This fragment contains the Cys 
residues 192 and 193 labeled by [3H]MBTA [6] and 
[3H]MPTA (this study) on the reduced AChR. It 
has also been reported that synthetic peptides cor- 
responding to this region of the o~-chain can bind 
or-toxins [26-28], albeit with low affinities and in 
an agonist-insensitive manner. The present finding 
that the majority of the incorporated [3H]DDF was 
associated with the fragment ot 179-207 shows that 
residues located within this region are actually in- 
volved in the binding of cholinergic ligands in the 
native AChR. 
The identities of the two additional [3H]DDF- 
labeled components were not determined in this 
study. Preliminary characterization f one of them 
(peak I), however, indicates that it is not a subfrag- 
ment of the major radiolabeled species. The 
specific incorporation of [3H]DDF into these two 
additional species suggests that regions of the or- 
chain distinct from that containing Cys 192 and 
193 may participate in the binding of cholinergic 
ligands. Evidence from a-toxin-binding ex- 
periments supports this idea [29] though the 
findings are controversial [30]. 
Further characterization f the [3H]DDF-labeled 
fragments, in particular the identification of the 
precise amino acids modified by this reagent, is 
currently in progress. These experiments hould 
provide a more detailed view of the structure of the 
ACh-binding site in its native conformation. 
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